2 APPG memberships (as of 9 Oct 2024)
Vulnerable Groups to Pandemics, War Crimes10 Former APPG memberships
Abraham Accords, Adult Social Care, Blood Cancer, Caribbean, Commonwealth, Get Refusal, Holocaust Memorial, Sovereign Wealth Funds, Stem Cell Transplantation and Advanced Cellular Therapies, VeteransDivision Voting information
Debates during the 2024 Parliament
Speeches made during Parliamentary debates are recorded in Hansard. For ease of browsing we have grouped debates into individual, departmental and legislative categories.
Sparring Partners
View All Sparring PartnersDepartment Debates
View All Department DebatesLegislation Debates
Lord Mendelsohn has not made any spoken contributions to legislative debateLords initiatives
These initiatives were driven by Lord Mendelsohn, and are more likely to reflect personal policy preferences.
1 Bill introduced by Lord Mendelsohn
A bill to make provision to amend the statutory limits for payment of invoices; make provision for a statutory time limit for resolving payment disputes; amend interest for late payments and penalties for persistent late payments and non-compliance; prohibit specified payment practices, on-boarding and pay-to-stay; require payments becoming due under public sector construction projects to be held in project bank accounts; amend the remit, role and powers of the Small Business Commissioner in regard to late payments; provide for a duty on auditors to publish late payment data; and for connected purposes
Lord Mendelsohn has not co-sponsored any Bills in the current parliamentary sitting
Latest 2 Written Questions
(View all written questions)Guidance from the UK Health Security Agency (UKHSA) states that there are very few individuals who cannot receive the COVID-19 vaccines approved in the United Kingdom. Anyone concerned about possible reactions to a vaccine should in the first instance speak to the clinician responsible for their care for advice. Published UKHSA clinical guidance for health professionals and immunisation practitioners on COVID-19 vaccination includes guidance for the management of patients with a history of allergy, including circumstances where a person may be referred to an expert allergist and, after a review of the individual’s risks and benefits of vaccination, and where it is indicated, they could then be vaccinated in hospital under clinical supervision. NHS England will continue to follow this clinical guidance and offer the appropriate vaccination to those who are eligible, including those who are immunocompromised, under expert supervision in a hospital setting, where appropriate.
Parliamentary Under-Secretary (Department of Health and Social Care)
The UK Health Security Agency (UKHSA) manages the central storage and distribution of COVID-19 vaccines for the United Kingdom’s programme. For the autumn and winter programme, the UKHSA has supplied both the Moderna COVID-19 vaccine (Spikevax) and the Pfizer-BioNTech COVID-19 vaccine (Comirnaty) to the National Health Service.
NHS England works closely with the regional and integrated care board (ICB) teams to ensure they deliver the right vaccine to the right place at the right time. Every ICB has received both vaccines as part of the autumn and winter campaign.
Parliamentary Under-Secretary (Department of Health and Social Care)